Completed PHASE2 INTERVENTIONAL 2-arm NCT01605799

IOK Treatment Study

A Novel PTSD Treatment for Veterans Who Killed in War

Sponsor: VA Office of Research and Development

Conditions Posttraumatic Stress Disorder

Interventions IOK Killing Treatment Wait list control group

Updated 5 times since 2017 Last updated: Jan 22, 2016 Started: Oct 31, 2012 Primary completion: Jan 31, 2015 Completion: Jan 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Posttraumatic Stress Disorder, this trial is completed. The trial is conducted by VA Office of Research and Development and has accumulated 5 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Oct 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

VA Office of Research and Development

Data source: VA Office of Research and Development

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• San Francisco, United States